J.P. Morgan Maintains Oric Pharmaceuticals(ORIC.US) With Buy Rating, Announces Target Price $23Market news · 7 Aug 2026
A Quick Look at Today's Ratings for Oric Pharmaceuticals(ORIC.US), With a Forecast Between $14 to $25Market news · 5 Aug 2026
H.C. Wainwright Maintains Oric Pharmaceuticals(ORIC.US) With Buy Rating, Raises Target Price to $27Market news · 10 Aug 2026
HC Wainwright & Co. Maintains Buy on ORIC Pharmaceuticals, Raises Price Target to $27Benzinga · 10 Aug 2026
HC Wainwright & Co. Reiterates Buy on ORIC Pharmaceuticals, Maintains $25 Price TargetBenzinga · 8 Jun 2026
Goldman Sachs Maintains Oric Pharmaceuticals(ORIC.US) With Buy Rating, Announces Target Price $15Market news · 3 Jun 2026
Analysts Offer Insights on Healthcare Companies: Ardent Health Partners, Inc. (ARDT), Tactile Systems Technology (TCMD) and Oric Pharmaceuticals (ORIC)TipRanks · 3 Jun 2026
Piper Sandler Maintains Oric Pharmaceuticals(ORIC.US) With Buy Rating, Maintains Target Price $22Market news · 29 Jun 2026
H.C. Wainwright Maintains Oric Pharmaceuticals(ORIC.US) With Buy Rating, Maintains Target Price $25Market news · 24 Jun 2026
Stifel Initiates Oric Pharmaceuticals(ORIC.US) With Buy Rating, Announces Target Price $14Market news · 12 Jun 2026
Stifel Maintains Oric Pharmaceuticals(ORIC.US) With Buy Rating, Maintains Target Price $14Market news · 12 Jun 2026
Wells Fargo Maintains Oric Pharmaceuticals(ORIC.US) With Buy Rating, Maintains Target Price $25Market news · 11 Jun 2026
Oppenheimer Maintains Oric Pharmaceuticals(ORIC.US) With Buy Rating, Maintains Target Price $15Market news · 5 May 2026
Goldman Sachs Initiates Oric Pharmaceuticals(ORIC.US) With Buy RatingMarket news · 15 May 2026
Discussion
No comments yet — be the first to weigh in on ORIC.
No comments yet — be the first to weigh in on ORIC.